EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Racial and Ethnic Disparities in European Breast Cancer Clinical Trials

Angelina Bania iD, Antonis Adamou iD, Emmanouil Saloustros iD

Cancers · 29.04.2024 · 16 (9) · 1726

DOI: 10.3390/cancers16091726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 29.04.2024. Verfasst von Angelina Bania und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, School of Health Sciences, University of Patras, 26504 Patras, Greece. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most prevalent female cancer worldwide with known correlations between the race and tumor characteristics of the patients and prognosis. International and US-based studies, however, have reported a disproportionate representation of Black and Hispanic patients in clinical trials. This is the first study assessing race and ethnicity reporting trends and inclusion in European breast cancer trials. The PubMed and ClinicalTrials.gov databases were systematically searched for trials on breast cancer treatment conducted exclusively in Europe between 2010 and 2022. Of the 97 identified trials, race was reported in 10.31%. Multinational participation, but not the study size or trial phase, was significantly associated with higher race reporting trends. These 10 trials featured a White-predominant population, with 1.08% Asian and 0.88% Black patients included. The acquisition of the race and ethnicity data of patients in European trials is lower compared to the U.S. or worldwide studies and does not permit extensive analysis of minority participation. In a limited analysis, the low rates of minority participation are concerning, based on population-based data on minorities in select European countries. These observations should encourage race reporting practices in European breast cancer trials and adequate minority participation to support the generalizability of the results of the studies and promote healthcare equity.

Schlagwörter

Stichwörter der Autor:innen

breast cancerclinical trialsethnicityinclusionminoritiesracerepresentation

Autor:innen und Institutionen

  • Faculty of Medicine, School of Health Sciences, University of Patras, 26504 Patras, Greece.
  • Institute of Diagnostic and Interventional Neuroradiology, Hannover Medical School, 30625 Hannover, Germany.
  • Division of Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41110 Larissa, Greece.

ORCID-Profile: Angelina Bania, Antonis Adamou, Emmanouil Saloustros

Zitieren

APA

Bania, A., Adamou, A., & Saloustros, E. (2024). Racial and Ethnic Disparities in European Breast Cancer Clinical Trials. Cancers, 16(9), 1726. https://doi.org/10.3390/cancers16091726

Vancouver

Bania A, Adamou A, Saloustros E. Racial and Ethnic Disparities in European Breast Cancer Clinical Trials. Cancers. 2024;16(9):1726. doi:10.3390/cancers16091726

BibTeX
@article{Bania2024,
  author = {Bania, Angelina and Adamou, Antonis and Saloustros, Emmanouil},
  title = {Racial and Ethnic Disparities in European Breast Cancer Clinical Trials},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {9},
  pages = {1726},
  doi = {10.3390/cancers16091726}
}
Kostenlos starten →